Yahoo Web Search

Search results

    • Investing in Taysha Gene Therapies Inc

      Knox Daily· 5 days ago

      B now holds 16,466,667 shares, worth roughly $50.88 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...

    • Savara (NASDAQ:SVRA) Price Target Cut to $7.00

      ETF DAILY NEWS· 6 days ago

      Savara (NASDAQ:SVRA – Free Report) had its price objective cut by Evercore ISI from $10.00 to $7.00 in a research note issued to investors on Thursday morning ...